The differences of clinicopathologic characteristics among subgroups of reclassified HER2 fluorescence in situ hybridization (FISH) according to the ASCO/CAP 2018 breast cancer HER2 testing guidelines.
| Autor: | Libo Yang, Min Chen, Tianjie Pu, Shuang Wu, Bing Wei, Jieliang Yang, Hong Bu, Zhang Zhang |
|---|---|
| Předmět: | |
| Zdroj: | Journal of Clinical Pathology; May2020, Vol. 73 Issue 5, p283-290, 8p, 1 Color Photograph, 5 Charts |
| Databáze: | Complementary Index |
| Externí odkaz: |
|